Recent investigations have focused on the overlap of GLP|glucose-dependent insulinotropic polypeptide|glucagon receptor agonist therapies and DA signaling. While GLP stimulators are increasingly employed for managing https://adreafmir289417.izrablog.com/41941292/emerging-gip-stimulators-and-dopamine-modulation-a-comparative-assessment